Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hanwha Aerospace (012450) – Clarification of Rumors or Reports / 2026-04-09 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Kiwoom Securities | 2Q25 Operating Profit Forecast of KRW 9.1 Trillion · Expansion of HBM3e 12hi · Short-Term Buy Valid / 2025-04-28 RESEARCH
  • [Research] SK hynix (000660 / SKHY) – Hanwha Investment & Securities | HBM Leadership Premium · Robust AI Server Demand · Target Price Raised / 2025-01-24 RESEARCH
  • [Disclosure] Celltrion (068270) – Market Measures Notice on Stock Futures and Options (Bonus Issue Adjustments) / 2025-06-05 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Kyobo Securities | 1Q24 Consensus Beat · NAND Turnaround · Target Price Upgraded / 2024-04-26 RESEARCH
  • [Disclosure] Hyundai Motor (005380) – Submission of Audit Report / 2024-03-06 Disclosures
  • [Disclosure] Jusung Engineering (036930) – Consolidated Financial Results (Provisional) / 2025-07-30 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Correction of Single Sales or Supply Contract / 2024-12-12 Disclosures

[Disclosure] Celltrion (068270) – Advance Notice of Financial Results Disclosure / 2025-02-14

Posted on February 14, 2025August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion announced that it expects to disclose its tentative financial results for FY2024 (2024-01-01 to 2024-12-31) on February 25, 2025.

📊 Key Disclosure Content & Financial Highlights

  1. Overview
  • Company: Celltrion, Inc. (Stock Code: 068270)
  • Disclosure Type: Advance Notice of Financial Results Disclosure (Informational Disclosure)
  1. Target Period & Expected Date
  • Target Fiscal Period: 2024-01-01 to 2024-12-31 (FY2024)
  • Expected Disclosure Date: 2025-02-25
  1. Additional Information
  • The financial results to be disclosed on the expected date are preliminary figures and subject to change depending on the external auditor’s review.
  • The scheduled date may change due to company circumstances.
  • Related IR materials (Korean/English) will be published on Celltrion’s official website under the IR section following the fair disclosure release.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of FY2024 Preliminary Financial Results Disclosure

This disclosure serves as official notification regarding the scheduled release date for Celltrion’s FY2024 preliminary earnings report. Checking whether the preliminary financial statements are released on the expected date of February 25, 2025, and reviewing key metrics such as annual revenue and operating profit, is important for evaluating the company’s fiscal performance. Relevant figures can be confirmed through the subsequent preliminary earnings disclosure or official IR materials.

📢 Disclaimer & Source Notice

Source: This content was structured and generated based on official disclosure data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Samsung Electronics (005930) – Delisting from Foreign Securities Market / 2025-02-13
Next Post: [Disclosure] Celltrion (068270) – Approval of European Commission Marketing Authorization for Eydenzelt (CT-P42, Eylea Biosimilar) / 2025-02-14

Related Posts

  • [Disclosure] ALTEOGEN (196170) – Trading Suspension and Resumption of Stock Futures and Options / 2026-07-16 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Acquisition of Shares in Other Corporation / 2025-01-08 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Conclusion of Single Sales/Supply Contract / 2025-12-11 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Change in Revenue or Income Structure Exceeding 30% (15% for Large Corporations) / 2026-02-04 Disclosures
  • [Disclosure] SK Square (402340) – Modification of Listing (Retirement of Shares) / 2024-04-18 Semiconductors
  • [Disclosure] SK Square (402340) – Change in Revenue or Profit/Loss Structure Exceeding 30% (15% for Large Enterprises) / 2025-02-11 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Decision on Retirement of Shares / 2025-02-18 Semiconductors
  • [Disclosure] LEENO Industrial (058470) – Closure of Shareholder Register or Designation of Record Date / 2023-12-12 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Execution of Single Sales or Supply Contract / 2025-12-23 Disclosures
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC (Zymfentra) in the U.S. (Rheumatoid Arthritis) / 2024-06-19 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Resolution on Board Meeting for General Meeting of Shareholders / 2025-02-18 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2024-06-25 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2025-08-20 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Sales / Supply Contract / 2025-03-31 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme